|Bid||0.00 x 47300|
|Ask||17.30 x 45900|
|Day's Range||16.58 - 16.70|
|52 Week Range||13.28 - 19.98|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.26 (1.51%)|
|1y Target Est||N/A|
Credit Suisse Group AG is seeking to grow its market share for a type of derivative that’s gaining favor among investors as a way to wager on corporate debt. The Swiss bank is ramping up its market-making operations for so-called total-return swaps tied to U.S. bond and loan indexes, according to people familiar with the matter. The lender hired Guillaume Sivadier from JPMorgan Chase & Co. earlier this year to oversee the effort, said the people, who asked not to be identified because they’re not authorized to speak about it.
On May 14, Teva (TEVA) stock increased ~5.5% on the news of the expected delay in the FDA approval for rival Perrigo’s (PRGO) generic version of Teva’s asthma inhaler ProAir. On May 14, Teva stock closed at a trading price of $20.38 per share.
The world’s second largest producer of bitcoin mining hardware could soon become the first cryptocurrency company to hit the public markets in Hong Kong. China’s Canaan Inc. applied Tuesday to trade on ...
Israel-based healthcare fund aMoon II has secured a $250 million (185 million pounds) investment commitment from Credit Suisse (CSGN.S), the fund’s managing partner Yair Schindel said on Wednesday. Last month the fund, which is investing in mid- to late-stage companies with a focus on fields like digital health, medical technology and biopharma in Israel, the United States and Europe, said it had raised $200 million from private investors. The Credit Suisse financing from its asset management and private banking divisions brings the fund close to meeting its target of $500 million.
Israel-based healthcare fund aMoon II has secured a $250 million investment commitment from Credit Suisse, the fund’s managing partner Yair Schindel said on Wednesday. Last month the fund, which is investing in mid- to late-stage companies with a focus on fields like digital health, medical technology and biopharma in Israel, the United States and Europe, said it had raised $200 million from private investors. The Credit Suisse financing from its asset management and private banking divisions brings the fund close to meeting its target of $500 million.
If HSBC Holdings Plc, UBS Group AG and Wells Fargo & Co. were concerned that the Trump administration might continue the big-ticket bank penalties of the Obama era, there are mounting signs that they need not be. Royal Bank of Scotland Group Plc says it has reached a tentative deal with the Justice Department to pay $4.9 billion to resolve an investigation into its sale of toxic mortgage-backed securities a decade ago. The Justice Department, without citing a figure, confirmed a pact was near.
Urban Outfitters, Credit Suisse, KLA-Tencor, Harsco and Grupo Simec as Zacks Bull and Bear of the Day
In 2018, the number of analysts tracking Air Products and Chemicals (APD) increased from 20 to 21, of which 76% have recommended “buy” and 24% have recommended “hold.” There have been no “sell” recommendations.
BlueVine said it will now raise the business line of credit it offers from its previous limit of $100,000 to a new limit of $250,000. It doubled the limit on its invoice factoring credit earlier this year to $5 million.
Credit Suisse (CSGN.S) still has work ahead after making good progress towards achieving targets set for a three-year turnaround, Chairman Urs Rohner told the group's annual general meeting on Friday. Credit Suisse this week delivered its best quarterly results since Chief Executive Tidjane Thiam in 2016 launched his restructuring plan for Switzerland's second-biggest bank, driven by its wealth management business. Credit Suisse on Wednesday confirmed the wind-down's completion by the end of this year and reiterated its cost-saving target of above 4.2 billion Swiss francs (3.07 billion pounds).
Credit Suisse Group AG on Wednesday posted a strong rise in first-quarter net profit, beating expectations and bolstering evidence that the Swiss lender’s yearslong restructuring has put it back on track to growth. Net profit grew 16% to 694 million Swiss francs ($709.1 million) as revenue rose 1.8% to 5.64 billion francs. Analysts had expected Credit Suisse to report net profit of 653 million francs on revenue of 5.49 billion francs.
Worries over rising bond yields and falling metals prices trumped well-received earnings updates from Kering and Credit Suisse on Wednesday, sending European shares to a one-week low. Concern remained over higher bond yields after the yield on the U.S. 10-year Treasury breached 3 percent level on Tuesday, making equities relatively less attractive. Caterpillar's results drove European industrials, after the company said it would steel tariffs would make it harder to pass on higher raw-material costs.
Credit Suisse shares rally after earningsVCG via Customers wait outside Gucci Store in Shanghai. Investors shoved European stocks lower Wednesday in the wake of a selloff on Wall Street where equities were spooked by rising bond yields and mixed earnings reports. Germany’s DAX 30 index (^GDAXI) was the worst performing among the major national indexes.
May.10 -- Sean Darby, chief global equity strategist at Jefferies & Co., Michael Cloherty, head of U.S. rates strategy at RBC Capital Markets, and Mandy Xu, chief equity derivatives strategist at Credit Suisse Group, discuss the impact of rising Treasury rates on equity markets with Bloomberg's Jonathan Ferro on "Bloomberg Markets: The Open."
May.10 -- Robert Santangelo, head of Americas ECM origination at Credit Suisse Securities, discusses the IPO environment and reaction from markets. He speaks with Alix Steel and David Westin on "Bloomberg Daybreak: Americas."
May.10 -- James Sweeney, Credit Suisse chief economist and chief investment officer Americas, discusses inflation and Federal Reserve rate hikes on "Bloomberg Surveillance."
May.04 -- Shahab Jalinoos, head of FX strategy at Credit Suisse Securities, and Bloomberg's Marty Schenker, discuss factors impacting currencies and monetary policy from the Bank of England. They speak with Francine Lacqua and Tom Keene on "Bloomberg Surveillance."
May.04 -- Shahab Jalinoos, head of FX strategy at Credit Suisse Securities, and Bloomberg's Marty Schenker, discuss U.S.-China trade talks and their impact on currencies. They speak with Francine Lacqua on "Bloomberg Surveillance."
May.03 -- Mark Connors, global head of risk advisory at Credit Suisse Securities, and Bloomberg Intelligence's Gina Martin Adams preview the trade talks between the U.S. and China with Bloomberg's Jonathan Ferro on "Bloomberg Markets: The Open."
May.03 -- Maggie Gage, head of Washington research at Credit Suisse Securities, discusses U.S.-China negotiations on trade. She speaks with David Westin on "Bloomberg Daybreak: Americas."
Apr.27 -- Credit Suisse Chief U.S. Equity Strategist Jonathan Golub discusses positive first-quarter earnings across the market and the outlook for future earnings. He speaks on "Bloomberg Surveillance."
Apr.27 -- Bloomberg's Amber Choudhury reports on the latest banking industry earnings, performance and news. She speaks on "Bloomberg Daybreak: Europe."
Apr.26 -- Michael O'Sullivan, chief investment officer for Europe, Middle East and Africa at Credit Suisse, and Max Kettner, cross asset strategist at Commerzbank, discuss European Central Bank monetary policy and EU economic data. They speak with Francine Lacqua on "Bloomberg Surveillance."